Non-invasive Biosensors Market is Estimated To Witness High Growth Owing To Increasing Demand for Non-invasive Medical Monitoring Devices
Non-invasive Biosensors Market
The global Non-invasive
Biosensors Market is estimated to be valued at US$ 2.7 Bn in 2017 and is expected to exhibit a CAGR of 12.1% over the forecast period
of 2018-2026, according to a new
report published by Coherent Market Insights.
Market Overview:
Non-invasive biosensors are devices that monitor various physiological
parameters without the need for invasive procedures such as blood sampling.
These devices offer several advantages, including painless measurements,
reduced risk of infection, and continuous monitoring capabilities. The
increasing prevalence of chronic diseases and the growing need for continuous
healthcare monitoring are driving the demand for non-invasive biosensors in the
market.
Market Key Trends:
One key trend in the non-invasive biosensors market is the increasing adoption
of wearable biosensors. These devices can be worn on the body and provide
continuous monitoring of various health parameters such as heart rate, blood
pressure, and glucose levels. The convenience and real-time monitoring
capabilities offered by wearable biosensors are driving their popularity among
consumers. In addition, advancements in sensor technology and miniaturization
have made these devices more portable and user-friendly, further fueling their
demand in the market.
Some of the key players operating in the non-invasive biosensors market include
Nemaura Medical, Inc., MediWise Ltd., Integrity Applications Inc., OrSense,
Medtronic Plc, GE Healthcare, Philips Healthcare, Akers Biosciences, Inc., and
Abbott Laboratories.
PEST Analysis:
Political: The political factors influencing the non-invasive biosensors market
include government regulations and policies related to healthcare and medical
devices. For example, the approval process for new biosensor technologies may
vary across different countries, which can impact market growth.
Economic: The economic factors affecting the market include healthcare
expenditure, disposable income, and reimbursement policies. Higher healthcare
expenditure and favorable reimbursement policies can drive the adoption of
non-invasive biosensors.
Social: Social factors such as an increasing prevalence of chronic diseases,
growing awareness about preventive healthcare, and the aging population
contribute to the demand for non-invasive biosensors. These devices offer a
convenient and cost-effective method for monitoring health conditions.
Technological: Technological advancements in biosensor technology, such as
miniaturization, improved accuracy, and wireless connectivity, are driving
market growth. These innovations enable the development of user-friendly and
wearable biosensors, enhancing the overall patient experience.
Key Takeaways:
The global Non-Invasive Biosensors Market is
expected to witness high growth, exhibiting a CAGR of 12.1% over the forecast
period. This growth can be attributed to several factors. Firstly, the
increasing prevalence of chronic diseases, such as diabetes, cardiac disorders,
and respiratory conditions, is driving the demand for non-invasive biosensors.
These devices provide real-time monitoring of various health parameters,
enabling early detection and timely intervention.
Regionally, North America is expected to be the fastest-growing and dominating
region in the non-invasive biosensors market. Factors such as advanced
healthcare infrastructure, high healthcare expenditure, and favorable
reimbursement policies contribute to the growth of the market in this region.
Additionally, the presence of key players and ongoing research and development
activities further drive market expansion in North America.
Key players operating in the non-invasive biosensors market include Nemaura Medical,
Inc., MediWise Ltd., Integrity Applications Inc., OrSense, Medtronic Plc, GE
Healthcare, Philips Healthcare, Akers Biosciences, Inc., and Abbott
Laboratories. These companies are actively involved in product development,
strategic collaborations, and mergers and acquisitions to strengthen their
market presence and expand their product portfolios.
Comments
Post a Comment